Overview
Emerging research highlights the impact of chronic aflatoxin exposure on vulnerable populations, including those who are immunocompromised, pregnant, or managing chronic conditions. Evidence links exposure to immune suppression, liver dysfunction, and increased disease progression.
Identifying mycotoxin exposure through tools like the MycoTOX Profile can support more informed clinical decision-making and targeted intervention.
You Might Also Like
View All News
Mosaic Diagnostics Announces Appointment of Scott Mattivi as Chief Executive Officer
Mosaic Diagnostics, a leading provider of specialty diagnostics, is proud to announce the appoin…
Mosaic Diagnostics and Evexia Diagnostics Partner to Expand Access to Innovative Specialty Diagnostics
Today, Mosaic Diagnostics and Evexia Diagnostics have announced a strategic partnership aimed at…
Stay Informed, Stay Ahead
Join the MosaicDX community and elevate your testing knowledge.